Sana Biotechnology SANA Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $71.87M-43.7% | $127.57M-4.5% | $133.52M-24.5% | $176.77M-30.1% | ||
| $66.51M+167% | $24.93M-65.2% | $71.68M-71.0% | $247.2M-17.0% | ||
| $4.2M+9.5% | $3.83M0.0% | $3.83M-37.2% | $6.1M-30.8% | ||
| $20.08M-23.1% | $26.12M-20.2% | $32.72M-24.3% | $43.23M+39.5% | ||
| $148.68M-7.5% | $160.81M-24.7% | $213.52M-52.0% | $444.44M-20.4% | ||
| $26.91M-65.2% | $77.31M+9.4% | $70.69M+5.6% | $66.92M+2.2% | ||
| $38.31M-33.9% | $57.96M-22.6% | $74.9M-19.0% | $92.49M-4.0% | ||
| $140.63M0.0% | $140.63M0.0% | $140.63M0.0% | $140.63M0.0% | ||
| $59.2M0.0% | $59.2M0.0% | $59.2M0.0% | $59.2M0.0% | ||
| $3.17M-38.0% | $5.12M-19.6% | $6.37M+38.5% | $4.6M-8.0% | ||
| $416.89M-16.8% | $501.02M-11.4% | $565.3M-31.3% | $822.72M-27.2% | ||
| $6.79M-62.5% | $18.11M-6.9% | $19.46M+32.4% | $14.69M+4.0% | ||
| $13.24M-8.4% | $14.45M-39.1% | $23.72M-10.0% | $26.36M+24.8% | ||
| $14.94M+19.2% | $12.53M-5.0% | $13.2M+6.5% | $12.39M+35.3% | ||
| $78.73M+73.3% | $45.43M-29.5% | $64.49M-42.2% | $111.5M+12.4% | ||
| $63.92M-21.7% | $81.66M-10.2% | $90.9M-5.2% | $95.86M-5.8% | ||
| $78.86M-16.3% | $94.2M-9.5% | $104.1M-3.8% | $108.25M-2.4% | ||
| $10.6M+7.1% | $9.9M— | —— | —— | ||
| $256.01M+2.2% | $250.52M-9.8% | $277.79M-14.1% | $323.41M-19.3% | ||
| $27K+22.7% | $22K+10.0% | $20K+5.3% | $19K+5.6% | ||
| $2.01B+8.3% | $1.86B+14.1% | $1.63B+4.3% | $1.56B+2.9% | ||
| -$1.85B-15.2% | -$1.6B-19.9% | -$1.34B-26.9% | -$1.05B-34.3% | ||
| $28K+100% | $14K+123% | -$60K+98.6% | -$4.33M-217% | ||
| $160.88M-35.8% | $250.5M-12.9% | $287.51M-42.4% | $499.32M-31.5% | ||
| $416.89M-16.8% | $501.02M-11.4% | $565.3M-31.3% | $822.72M-27.2% | ||
| $66.51M+167% | $24.93M-65.2% | $71.68M-71.0% | $247.2M-17.0% | ||
| $3.17M-38.0% | $5.12M-19.6% | $6.37M+38.5% | $4.6M-8.0% | ||
| $38.31M-33.9% | $57.96M-22.6% | $74.9M-19.0% | $92.49M-4.0% | ||
| $59.2M0.0% | $59.2M0.0% | $59.2M0.0% | $59.2M0.0% | ||
| $38.31M-33.9% | $57.96M-22.6% | $74.9M-19.0% | $92.49M-4.0% | ||
| $3.17M-38.0% | $5.12M-19.6% | $6.37M+38.5% | $4.6M-8.0% | ||
| $38.31M-33.9% | $57.96M-22.6% | $74.9M-19.0% | $92.49M-4.0% | ||
| $3.17M-38.0% | $5.12M-19.6% | $6.37M+38.5% | $4.6M-8.0% | ||
| $13.24M-8.4% | $14.45M-39.1% | $23.72M-10.0% | $26.36M+24.8% | ||
| $13.24M-8.4% | $14.45M-39.1% | $23.72M-10.0% | $26.36M+24.8% | ||
| $83.52M-23.4% | $108.97M-0.6% | $109.61M+15.3% | $95.03M-7.2% | ||
| $8.68M-34.4% | $13.24M-43.6% | $23.46M+61.3% | $14.55M+40.6% | ||
| $78.86M-16.3% | $94.2M-9.5% | $104.1M-3.8% | $108.25M-2.4% | ||
| $27K+22.7% | $22K+10.0% | $20K+5.3% | $19K+5.6% | ||
| $19.24M+322% | $4.56M-64.4% | $12.8M-39.1% | $21.01M-78.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Sana Biotechnology's total assets?
- Sana Biotechnology (SANA) holds $373.6M in total assets, down 16.1% year over year.
- How much debt does Sana Biotechnology have?
- Sana Biotechnology carries $75.3M in total debt against $119.2M of shareholders' equity, a debt-to-equity ratio of 0.63.
- How much cash does Sana Biotechnology have?
- Sana Biotechnology holds $83.8M in cash and equivalents.
- Can Sana Biotechnology cover its short-term obligations?
- Its current ratio is 1.29 — current assets exceed current liabilities.
- Where does Sana Biotechnology's balance sheet data come from?
- Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.